Distribution of Langerhans cells and expression of MCP-1 in skin lesions of Bowenoid papulosis and their clinical significance

朱宁,周强,韩睿,程浩
DOI: https://doi.org/10.12056/j.issn.1006-2785.2018.40.9.2018-460
2018-01-01
Abstract:Objective To investigate the distribution of Langerhans cells (LCs) and the expression of monocyte chemoattractant protein-1 (MCP-1) in skin lesions of Bowenoid papulosis (BP) and their clinical significance. Methods The expression of CD1a (marker of LC) and MCP-1 in skin lesions and adjacent normal skin tissue of 36 patients with BP were detected with immunohistochemical staining. The correlation between the density of CD1a+ LCs and MCP-1 expression was analyzed. Results CD1a+ LCs was mainly expressed in dendritic cells in the spinous layer of the epidermis. MCP-1 was mainly expressed in the cytoplasm of epidermal keratinocytes. In epidermal BP lesions, CD1a+ LCs density was lower, and these cells exhibited an abnormal distribution and shorter protrusions, and MCP-1 staining was weaker and the semi-quantitative score of MCP-1 expression was lower than those in the adjacent normal epidermal tissue. The density of CD1a+ LCs was positively correlated with MCP-1 expression in BP lesions and the adjacent normal skin tissue. Conclusion The decreased LC density and degenerated LC morphology in the epidermis may be related to the down-regulation of MCP-1 expression in BP lesions, ultimately leading to immune suppression.
What problem does this paper attempt to address?